Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-18
2010-10-26
Szperka, Michael (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S004300, C514S008100, C424S184100
Reexamination Certificate
active
07820617
ABSTRACT:
The invention relates to the field of immunology. Specifically, the invention relates to the field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease or inflammatory disease. The invention provides for an immunoregulator (IR), use of an IR in preparing a pharmaceutical composition for treating an immune-mediated disorder and a method for treating an immune-mediated disorder.
REFERENCES:
patent: 4330466 (1982-05-01), Yanaihara et al.
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 4571336 (1986-02-01), Houck et al.
patent: 4753965 (1988-06-01), Stemerick et al.
patent: 4855285 (1989-08-01), Stevens
patent: 4977244 (1990-12-01), Muchmore et al.
patent: 5002961 (1991-03-01), Dage et al.
patent: 5010175 (1991-04-01), Rutter et al.
patent: 5055447 (1991-10-01), Palladino et al.
patent: 5223397 (1993-06-01), Pouletty
patent: 5308834 (1994-05-01), Scott et al.
patent: 5380668 (1995-01-01), Herron
patent: 5436270 (1995-07-01), Wang
patent: 5677275 (1997-10-01), Lundari-Iskandar et al.
patent: 5700781 (1997-12-01), Harris
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5837478 (1998-11-01), Gallatin et al.
patent: 5851997 (1998-12-01), Harris
patent: 5854004 (1998-12-01), Czernilofsky et al.
patent: 5856440 (1999-01-01), Wang
patent: 5877148 (1999-03-01), Lundari-Iskandar et al.
patent: 5942494 (1999-08-01), Ginsberg et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5966712 (1999-10-01), Sabatini et al.
patent: 5968513 (1999-10-01), Gallo et al.
patent: 5972924 (1999-10-01), Keep et al.
patent: 5981486 (1999-11-01), Matsushima et al.
patent: 5994126 (1999-11-01), Steinman et al.
patent: 5997871 (1999-12-01), Gallo et al.
patent: 6022696 (2000-02-01), Harding et al.
patent: 6051596 (2000-04-01), Badger
patent: 6075150 (2000-06-01), Wang et al.
patent: 6086918 (2000-07-01), Stern et al.
patent: 6150500 (2000-11-01), Salemo
patent: 6207145 (2001-03-01), Tovey
patent: 6235281 (2001-05-01), Stenzel et al.
patent: 6271199 (2001-08-01), Brand et al.
patent: 6278794 (2001-08-01), Parekh et al.
patent: 6309822 (2001-10-01), Fodor et al.
patent: 6310041 (2001-10-01), Haddux et al.
patent: 6319504 (2001-11-01), Gallo et al.
patent: 6361992 (2002-03-01), Szkudlinski et al.
patent: 6379970 (2002-04-01), Liebler et al.
patent: 6416959 (2002-07-01), Giuliano et al.
patent: 6489296 (2002-12-01), Grinnell et al.
patent: 6507788 (2003-01-01), Camara y Ferrer et al.
patent: 6518021 (2003-02-01), Thastrup et al.
patent: 6539102 (2003-03-01), Anderson et al.
patent: 6583109 (2003-06-01), Gallo et al.
patent: 6586403 (2003-07-01), Mathison et al.
patent: 6596688 (2003-07-01), Gallo et al.
patent: 6620416 (2003-09-01), Gallo et al.
patent: 6630138 (2003-10-01), Gerlitz et al.
patent: 6652860 (2003-11-01), Singh et al.
patent: 6699656 (2004-03-01), Gallo et al.
patent: 6711563 (2004-03-01), Koskas
patent: 6727227 (2004-04-01), Khavinson
patent: 6783757 (2004-08-01), Brudnak
patent: 6831057 (2004-12-01), Baldwin et al.
patent: 6844315 (2005-01-01), Khan et al.
patent: 6852697 (2005-02-01), Mathison et al.
patent: 6894028 (2005-05-01), Lipton et al.
patent: 6921751 (2005-07-01), Khan et al.
patent: 7094760 (2006-08-01), Mathison et al.
patent: 7135286 (2006-11-01), Margus et al.
patent: 7175679 (2007-02-01), Khan et al.
patent: 7316819 (2008-01-01), Crotts et al.
patent: 7358330 (2008-04-01), Khan et al.
patent: 7365155 (2008-04-01), Khan et al.
patent: 7368535 (2008-05-01), Ouspenski
patent: 7402322 (2008-07-01), Khan et al.
patent: 7501391 (2009-03-01), Khan et al.
patent: 2002/0041871 (2002-04-01), Brudnak
patent: 2002/0147306 (2002-10-01), Lin et al.
patent: 2003/0049273 (2003-03-01), Gallo et al.
patent: 2003/0113733 (2003-06-01), Khan et al.
patent: 2003/0119720 (2003-06-01), Khan et al.
patent: 2003/0166556 (2003-09-01), Khan et al.
patent: 2003/0186244 (2003-10-01), Margus et al.
patent: 2003/0215434 (2003-11-01), Khan et al.
patent: 2003/0219425 (2003-11-01), Khan et al.
patent: 2003/0220257 (2003-11-01), Benner et al.
patent: 2003/0220258 (2003-11-01), Benner et al.
patent: 2003/0220259 (2003-11-01), Benner et al.
patent: 2003/0220260 (2003-11-01), Khan et al.
patent: 2003/0220261 (2003-11-01), Khan et al.
patent: 2003/0224995 (2003-12-01), Khan et al.
patent: 2004/0013661 (2004-01-01), Wensvoort et al.
patent: 2004/0208885 (2004-10-01), Khan et al.
patent: 2005/0037430 (2005-02-01), Khan et al.
patent: 2005/0107314 (2005-05-01), Gorczynski et al.
patent: 2005/0214943 (2005-09-01), Khan et al.
patent: 2005/0227925 (2005-10-01), Benner et al.
patent: 2006/0111292 (2006-05-01), Khan et al.
patent: 2006/0142205 (2006-06-01), Benner et al.
patent: 2006/0275255 (2006-12-01), Gudkov
patent: 2007/0197447 (2007-08-01), Khan et al.
patent: 2008/0076714 (2008-03-01), Khan et al.
patent: 2008/0171094 (2008-07-01), Benner et al.
patent: 2008/0176243 (2008-07-01), Khan et al.
patent: 2008/0194489 (2008-08-01), Khan et al.
patent: 2008/0242618 (2008-10-01), Khan et al.
patent: 2008/0242837 (2008-10-01), Khan et al.
patent: 3715662 (1987-11-01), None
patent: 19953339 (2003-05-01), None
patent: 0 572 688 (1997-05-01), None
patent: 1 138 692 (2001-10-01), None
patent: 1 300 418 (2003-04-01), None
patent: 1 224 212 (2003-07-01), None
patent: 1 466 612 (2004-10-01), None
patent: 2706772 (1994-12-01), None
patent: 2 194 886 (1988-03-01), None
patent: WO 92/20795 (1992-11-01), None
patent: WO 96/04008 (1996-02-01), None
patent: WO 96/33218 (1996-10-01), None
patent: WO 97/04008 (1997-02-01), None
patent: WO 97/49373 (1997-12-01), None
patent: WO 97/49418 (1997-12-01), None
patent: WO 97/49432 (1997-12-01), None
patent: WO 97/49721 (1997-12-01), None
patent: WO 98/06742 (1998-02-01), None
patent: WO 98/34631 (1998-08-01), None
patent: WO 98/35691 (1998-08-01), None
patent: WO 99/31227 (1999-06-01), None
patent: WO 99/59617 (1999-11-01), None
patent: WO 00/17348 (2000-03-01), None
patent: WO 01/10907 (2001-02-01), None
patent: WO 01/11048 (2001-02-01), None
patent: WO 0110457 (2001-02-01), None
patent: WO 01/29067 (2001-04-01), None
patent: WO 01/29069 (2001-04-01), None
patent: WO 01/32196 (2001-05-01), None
patent: WO 01/36454 (2001-05-01), None
patent: WO 01/51508 (2001-07-01), None
patent: WO 01/68113 (2001-09-01), None
patent: WO 01/72831 (2001-10-01), None
patent: WO 01/83554 (2001-11-01), None
patent: WO 02/085117 (2002-10-01), None
patent: WO 03-029292 (2003-04-01), None
patent: WO 2006/069198 (2006-06-01), None
Barton, BE et al. Infection and Immunity [1993] 61(4):1496-1499.
Khavinson et al., “Mechanisms Underlying Geroprotective Effects of Peptides,” Bulletin of Experimental Biology and Medicine, Jan. 2002, pp. 1-5, vol. 133, No. 1.
Khavinson et al., “Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell,” Bulletin of Experimental Biology and Medicine, May 2004, pp. 503-506, vol. 137, No. 5.
Morozov et al., “Natural and Synthetic Thymic Peptides as Therapeutics for Immune Dysfunction,” Int. J. Immunopharmac., 1997, pp. 501-505, vol. 19, No. 9/10.
Khavinson et al., “Inductive Activity of Retinal Peptides,” Bulletin of Experimental Biology and Medicine, Nov. 2002, pp. 482-484, vol. 134, No. 5.
Khavinson et al., “Effects of Short Peptides on Lymphocyte Chromatin in Senile Subjects,” Bulletin of Experimental Biology and Medicine, Jan. 2004, pp. 78-81, vol. 137, No. 1.
Khavinson et al., “Effects of Livagen Peptide on Chromatin Activation in Lymphocytes from Old People,” Bulletin of Experimental Biology and Medicine, Oct. 2002, pp. 389-392, vol. 134, No. 4.
Khavinson et al., “Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells,” Bulletin of Experimental Biology and Medicine, Jun. 2003, pp. 590-592, vol. 135, No. 6.
Ivanov et al., “Hemoglobin as a Source of Endogenous Bioactive Peptides: The Concept of Tissue-Specific Peptide Pool,” Biopolymers, 1997, pp. 171-188, vol. 39.
Khavinson et al, Gerontological Aspects of Genome Peptide Regulation, 2005, S. Karger AG, Basel, Swi
Benner Robbert
Khan Nisar Ahmed
Biotempt B.V.
Szperka Michael
TraskBritt
LandOfFree
Methods of selecting immunoregulator peptides obtained from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of selecting immunoregulator peptides obtained from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of selecting immunoregulator peptides obtained from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162316